載入...

(86/90)Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics

Pancreatic cancer is highly aggressive, with a median survival time of less than 6 months and a 5-year overall survival rate of around 7%. The poor prognosis of PaCa is largely due to its advanced stage at diagnosis and the lack of efficient therapeutic options. Thus, the development of an efficient...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Pharm
Main Authors: Ferreira, Carolina A., Ehlerding, Emily B., Rosenkrans, Zachary T., Jiang, Dawei, Sun, Tuanwei, Aluicio-Sarduy, Eduardo, Engle, Jonathan W., Ni, Dalong, Cai, Weibo
格式: Artigo
語言:Inglês
出版: 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7265990/
https://ncbi.nlm.nih.gov/pubmed/32202792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.0c00127
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!